Skip to main content
. 2017 Jul 27;91(16):e00519-17. doi: 10.1128/JVI.00519-17

TABLE 2.

Antiviral activity of representative compounds against drug-resistant HBV mutants

Compound Mean EC50 ± SD (μM)a
NUC sensitive, WT ADV resistant
3TC resistant, rtM204I 3TC/ETV resistant, rtL180M, rtM204V, rtT184G, rtS202I
rtA181V rtN236T
3TC 0.029 ± 0.0007 0.110 ± 0.007 0.064 ± 0.09 >10.000 >10.000
ETV 0.001 ± 0.0001 0.002 ± 0.001 0.0002 ± 0.0001 0.055 ± 0.0007 1.100 ± 0.140
BA-38017 1.04 ± 0.01 1.51 ± 0.18 1.91 ± 0.07 0.75 ± 0.07 1.59 ± 0.07
a

From duplicate experiments.